RYBOX Mutual Fund (Rydex Biotechnology Fund Class A) is managed by Rydex Funds with $15.0M in net assets. RYBOX expense ratio is 1.64%, holding 76 positions across sectors including Health Care, Unknown, Materials. Inception date: 2004-09-01.

RYBOX performance shows a YTD return of 3.94%. The 1-year return is 46.68% and the 5-year return is 9.53%. RYBOX dividend yield stands at 14.60%, paid annually.

RYBOX top holdings include Abbvie Inc (8.8%), Amgen Inc. (5.3%), Gilead Sciences Inc (4.9%), Nvaesrtex Pharmaceuticals Inc (4.3%), Alnylam Pharmace (3.3%). View all RYBOX holdings, sector breakdown, or dividend history.

RYBOX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RYBOX alternatives are available via the screener, along with tax-loss harvesting opportunities.